|
UIMC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.22090115795004E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.06849995518132E-09 |
| Normal-vs-Stage2 |
3.62999999999891E-05 |
| Normal-vs-Stage3 |
2.1893997725897E-10 |
| Normal-vs-Stage4 |
7.09969860679394E-11 |
| Stage1-vs-Stage2 |
9.511000E-01 |
| Stage1-vs-Stage3 |
2.710800E-01 |
| Stage1-vs-Stage4 |
1.164770E-01 |
| Stage2-vs-Stage3 |
4.666200E-01 |
| Stage2-vs-Stage4 |
3.095400E-01 |
| Stage3-vs-Stage4 |
6.715000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.93890484065673E-11 |
| Normal-vs-AfricanAmerican |
2.32019999999444E-05 |
| Normal-vs-Asian |
1.58816999999978E-05 |
| Caucasian-vs-AfricanAmerican |
9.386400E-01 |
| Caucasian-vs-Asian |
3.849000E-01 |
| AfricanAmerican-vs-Asian |
5.039200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.89089999214076E-09 |
| Normal-vs-Female |
5.73420200211672E-11 |
| Male-vs-Female |
7.309200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.26399998537863E-09 |
| Normal-vs-Age(41-60Yrs) |
2.86759949119642E-10 |
| Normal-vs-Age(61-80Yrs) |
7.21139814530147E-11 |
| Normal-vs-Age(81-100Yrs) |
4.378800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.303000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.679800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.261800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.463170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.849000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.763800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.164100E-02 |
| Classical-VS-Follicular |
3.662200E-03 |
| Classical-VS-Other |
8.362800E-01 |
| Classical-VS-Normal |
1.50129999543225E-08 |
| Tall-VS-Follicular |
7.027400E-01 |
| Tall-VS-Other |
5.066800E-01 |
| Tall-VS-Normal |
1.49200000021388E-07 |
| Follicular-VS-Other |
4.464400E-01 |
| Follicular-VS-Normal |
9.02089514198678E-11 |
| Other-VS-Normal |
1.324300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.71251942918616E-12 |
| Normal-vs-N1 |
1.54199997215443E-09 |
| N0-vs-N1 |
3.752600E-01 |
|
|
